<DOC>
	<DOCNO>NCT01564979</DOCNO>
	<brief_summary>The purpose study determine whether pretarsal preseptal technique Botulinum toxin type A injection effect tear function .</brief_summary>
	<brief_title>Effect Tear Functions Pretarsal Preseptal Techniques Botulinum Toxin Type A Injection Hemifacial Spasm</brief_title>
	<detailed_description>Botulinum toxin type A use hemifacial spasm since 1986. Botulinum toxin type A subcutaneously inject pretarsal preseptal portion orbicularis muscle . Blepharoptosis report less frequently pretarsal technique , however dry eye notice one patient treat pretarsal botulinum toxin type A cosmetic purpose .</detailed_description>
	<mesh_term>Spasm</mesh_term>
	<mesh_term>Muscle Cramp</mesh_term>
	<mesh_term>Hemifacial Spasm</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>patient diagnose hemifacial spasm previous history botulinum toxin treatment hemifacial spasm ocular surface disorder tear disorder evidence infection around eyelid pregnant woman neurologic disease , i.e . OMG coagulopathy treatment thrombolytic agent treatment aminoglycosides , chloroquine , hydroxychloroquine</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>botulinum toxin</keyword>
	<keyword>facial nerve</keyword>
	<keyword>hemifacial spasm</keyword>
	<keyword>tear</keyword>
</DOC>